ArticleFrontiers in immunology2025
The mediating role of biological age in the association between dietary index for gut microbiota and sarcopenia.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Longitudinal associations of sarcopenia and biological age acceleration with rate of cognitive decline.BMC public health · 2026Article
- Gut-muscle axis in sarcopenia: from mechanisms to microbiome-based therapies.Frontiers in nutrition · 2026Review
- Biological aging mediates and frailty modifies the associations of arterial stiffness with incident probable sarcopenia and sarcopenia: a prospective cohort study of UK biobank.Frontiers in public health · 2026Article
- Associations between dietary index for gut microbiota with COPD prevalence and all-cause mortality: insights from the 1999-2018 NHANES data.BMC pulmonary medicine · 2025Article
- Association of the newly proposed dietary index for gut microbiota and all-cause and cardiovascular mortality among individuals with diabetes and prediabetes.Frontiers in nutrition · 2025Article
- Association between the newly proposed dietary index for gut microbiota and thyroid function: NHANES 2007-2012.Frontiers in nutrition · 2025Article
- Association between dietary index for gut microbiota and sleep duration in US adults: a cross-sectional study.Current research in microbial sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dietary Index of Gut Microbiota (DI-GM) is a newly proposed comprehensive metric for assessing dietary quality in relation to gut microbiota composition. Alterations in muscle structure are closely linked to DNA methylation-based biological age assessments and individual dietary patterns. However, a systematic investigation of the interrelationships among DI-GM, biological age, and sarcopenia remains lacking. We hypothesize that consuming foods beneficial to the gut microbiota may help mitigate the risk of sarcopenia by slowing the aging process. Methods: This study analyzed data from NHANES 2007-2018. DI-GM was calculated using two 24-hour dietary recall datasets. Sarcopenia was assessed via dual-energy X-ray absorptiometry (DXA). The association between DI-GM and sarcopenia was evaluated using multivariate logistic regression, subgroup analysis, and restricted cubic splines. This study also investigated the potential mediating effects of three biological age indicators: the Klemera-Doubal Method (KDM), PhenoAge, and Homeostatic Dysregulation (HD). Results: An increase in DI-GM score was significantly associated with a reduced risk of sarcopenia (OR: 0.87, 95% CI: 0.82-0.94).The risk of sarcopenia was significantly lower in the highest quartile group (Q3) (OR: 0.25, 95% CI: 0.11-0.58). The three biological age-related indicators (KDM, PA, and HD) partially mediated the association between DI-GM and sarcopenia, with PhenoAge showing the highest mediation proportion at 30.6%. Conclusion: A higher DI-GM score was significantly associated with a reduced risk of sarcopenia. PhenoAge, HD, and KDM demonstrated significant mediating effects, with PhenoAge showing the highest mediation proportion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.